retatrutide mechanism clinical trial retatrutide Retatrutide's mechanisms of action A new weight-loss drug called
Description
Explore the mechanisms, clinical applications, and future opportunities of GLP-1 receptor agonists in drug development and disease management.
Contents: Retatrutide
Credits: istock.org
Learn what results to realistically expect.
Semaglutide was approved in 2017 as Ozempic for diabetes, and in 2021 as Wegovy for obesity
Since their introduction in 2005, GLP-1 medications like Ozempic and Wegovy have transformed diabetes treatment and weight management
